Mild Head Trauma in the Emergency Room: Assessment of the Risk of Intracranial Hemorrhage in Patients Receving Platelet Inhibitors.

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05589103

Acronym

Trauma-Head

Enrollment

1692

Registered

2022-10-21

Start date

2020-01-01

Completion date

2022-12-31

Last updated

2022-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head Trauma Injury

Keywords

Head Trauma Injury, Head Trauma, Traumatic Intracranial Hemorrhage, Antiaggregants, Platelet

Brief summary

The clinical signs presented by a patient with a mild head injury are highly variable but remain strongly predictive of brain damage. The reference examination for the diagnosis of post-traumatic intracranial hemorrhage is currently the cerebral scanner without injection of contrast medium. Magnetic resonance imaging (MRI) tends to surpass CT in equipped centers, except for suspected bone lesions. The time required to perform brain imaging depends on the patient's clinical condition, comorbidities and treatments. The responsibility of antiplatelet agents in post-traumatic intracranial hemorrhage is currently discussed, particularly with aspirin. The hypothesis is that there is no significant difference in the proportion of intracranial hemorrhage in patients on antiplatelet agents after mild head trauma, in the absence of other factors favoring the occurrence of intracranial hemorrhage.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Inclusion criteria

* Adult patient (≥18 years old) * Visit to the emergency room of the Strasbourg University Hospital during 2017 * Victim of mild head trauma * Patient who has given their consent to the reuse of their data for the purposes of this research. Non-inclusion criteria * Patient who expressed their opposition to participating in the study * Subject under safeguard of justice * Subject under guardianship or curatorship * Patient on anticoagulant * Non-isolated head trauma (AVP, fall greater than 6 meters, etc.)

Design outcomes

Primary

Measure	Time frame
Propensity score on the factors influencing the taking of antiplatelet agents.	Files analysed retrospectively from January 01, 2017 to December 31, 2017 will be examined

Countries

France

Contacts

Primary ContactFlorent BAICRY, MD

florent.baicry@chru-strasbourg.fr33 3 69 55 03 86

Outcome results